Clinical trial · Interventional
Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer
Acupuncture for the Treatment of Pancreatic Cancer Pain: A Single Arm Phase II Study
NCT00040833CI-TRIAL-00010623completedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Acupuncture and acupressure may help relieve moderate or severe pain associated with stage III or stage IV pancreatic cancer. PURPOSE: Phase II trial to study the effectiveness of acupuncture and accupressure in treating patients who have moderate or severe pain associated with stage III or stage IV pancreatic cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pain | — | UNRESOLVED | — |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| complementary or alternative medicine procedure | Procedure | — | UNRESOLVED |
| pain therapy | Procedure | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Diagnosis of stage III or IV primary pancreatic cancer * At least 4 days since prior change in type of pain medication * No change in dose of long-acting analgesics * Actual dose of as needed (PRN) pain medication may vary * One of the following pain scores: * Pain score of at least 4 on a scale of 0 to 10 * A score of at least 54 out of 88 on the combined relevant Profile of Mood States (POMS) subscales (Vigor, Fatigue, and Confusion) with no evidence that sedation results from cause other than opiate medication and patient reported using PRN opiates on at least 4 of the past 7 days (patients who are eligible for this study on the basis of POMS scores must be taking PRN medication) PATIENT CHARACTERISTICS: Age: * Over 18 Performance status: * Not specified Life expectancy: * At least 4 weeks Hematopoietic: * Absolute neutrophil count at least 500/mm\^3 * Platelet count at least 20,000/mm\^3 Hepatic: * INR no greater than 2.5 Renal: * Not specified Cardiovascular: * No heart valve dysfunction Other: * No uncontrolled infection PRIOR CONCURRENT THERAPY: Biologic therapy: * Not specified Chemotherapy: * At least 4 weeks since prior gemcitabine unless there is documented disease progression * Concurrent chemotherapy (except gemcitabine) allowed Endocrine therapy: * Not specified Radiotherapy: * At least 3 weeks since prior radiotherapy * No concurrent radiotherapy Surgery: * At least 1 week since prior epidural analgesia, celiac plexus block, or thoracoscopic or open splanchnicectomy * No concurrent epidural analgesia, celiac plexus block, or thoracoscopic or open splanchnicectomy Other: * See Disease Characteristics * At least 3 months since prior acupuncture * Concurrent experimental treatments allowed
References
Publications (0)
Data not yet available
No reference posted for this study.